Related Experiment Video
Updated: Aug 29, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
What every cardiologist should know about intravascular contrast
1Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Insights
Cardiologists debate contrast agents for angiography. This summary covers cost-effectiveness of low osmolar contrast and nonionic agent prothrombogenicity, crucial for vascular disease diagnosis and treatment.
Area of Science:
- Cardiovascular Imaging
- Radiology
- Interventional Cardiology
Background:
- Contrast-enhanced X-ray imaging is vital for diagnosing and treating cardiac and vascular diseases.
- Traditional angiography offers unparalleled high-resolution, real-time, dynamic vascular visualization.
- Advancements in imaging have prompted reevaluation of contrast agent selection.
Observation:
- Concerns regarding contrast agents have led to debates on cost-effectiveness, prothrombogenicity, and nephrotoxicity.
- Focus is placed on low osmolar contrast agents and nonionic agents.
- Clinical relevance of these aspects is critical for proceduralists and referring physicians.
Findings:
- The summary addresses the cost-effectiveness of low osmolar contrast media.
- It also examines the prothrombogenic potential of nonionic contrast agents.
- These factors influence patient management and procedural outcomes.
Implications:
- Understanding contrast agent properties is essential for optimal patient care in cardiovascular procedures.
- Informed contrast selection can mitigate risks and improve diagnostic accuracy.
- This knowledge impacts both the performance of angiography and post-procedure patient follow-up.
Abstract:
Contrast-enhanced x-ray imaging remains essential to the diagnosis and treatment of many types of cardiac and vascular disease. Despite the rapid advancements in less invasive imaging techniques, only traditional angiography provides a high-resolution, real-time, dynamic view of vascular structures. Cardiologists have become concerned about contrast selection since the introduction of new agents over the last 2 decades. This concern has sparked three sequential debates within our community: the cost effectiveness of low osmolal contrast; whether nonionic agents are prothrombogenic; and whether the potential for nephrotoxicity differs between contrasts. Following is a summary of clinically relevant aspects of the cost effectiveness of low osmolal contrast and the prothrombogenicity of nonionic agents. These issues are important not only to those who perform angiography, but also to those who refer patients to, or follow them after, the procedure.
More Related Videos
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies III: Computed Tomography
Imaging Studies VII: Vascular Imaging
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management